Insiders · OCUP

OCUP insider transactions

Ocuphire Pharma Inc. (OCUP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for OCUP

• 591d
  SEC Form 4 filed by Director Graves Adrienne L

  4 - Opus Genetics, Inc. (0001228627) (Issuer)
• 591d
  Director Bennett Jean was granted 100,000 shares (SEC Form 4)

  4 - Opus Genetics, Inc. (0001228627) (Issuer)
• 591d
  SEC Form 3 filed by new insider Yerxa Benjamin R

  3 - Opus Genetics, Inc. (0001228627) (Issuer)
• 591d
  SEC Form 3 filed by new insider Graves Adrienne L

  3 - Opus Genetics, Inc. (0001228627) (Issuer)
• 591d
  SEC Form 3 filed by new insider Bennett Jean

  3 - Opus Genetics, Inc. (0001228627) (Issuer)
• 724d
  Director Rodgers Richard J was granted 41,143 shares, increasing direct ownership by 21% to 239,151 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 724d
  Director Pepose Jay was granted 41,143 shares, increasing direct ownership by 30% to 180,458 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 724d
  Director Manuso James S J was granted 41,143 shares, increasing direct ownership by 45% to 132,037 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 724d
  Director Gallagher Cam was granted 41,143 shares, increasing direct ownership by 115% to 77,047 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 724d
  Director Benton Susan was granted 41,143 shares, increasing direct ownership by 42% to 140,023 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 724d
  Director Ainsworth Sean was granted 41,143 shares, increasing direct ownership by 87% to 88,358 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 744d
  Jayagopal Ashwath bought $6,178 worth of shares (3,500 units at $1.76), increasing direct ownership by 5% to 78,500 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 747d
  Magrath George bought $8,772 worth of shares (5,000 units at $1.75), increasing direct ownership by 1% to 430,000 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 783d
  Pepose Jay was granted 32,000 shares, increasing direct ownership by 30% to 139,315 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 804d
  Schachle Joseph K bought $4,100 worth of shares (2,000 units at $2.05) (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 804d
  Jhaveri Nirav S. bought $21,000 worth of shares (10,000 units at $2.10), increasing direct ownership by 7% to 150,000 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 809d
  Magrath George bought $49,050 worth of shares (25,000 units at $1.96), increasing direct ownership by 6% to 425,000 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 844d
  Jhaveri Nirav S. was granted 140,000 shares (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 844d
  Jayagopal Ashwath was granted 75,000 shares (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 844d
  SEC Form 3 filed by new insider Jhaveri Nirav S.

  3 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 844d
  SEC Form 3 filed by new insider Jayagopal Ashwath

  3 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 867d
  Hoffmann Bernhard was granted 20,000 shares, increasing direct ownership by 14% to 162,697 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 867d
  Zaremba Rabourn Amy was granted 40,000 shares, increasing direct ownership by 94% to 82,658 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 877d
  Hoffmann Bernhard covered exercise/tax liability with 4,031 shares, decreasing direct ownership by 3% to 142,697 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 877d
  Zaremba Rabourn Amy covered exercise/tax liability with 3,950 shares, decreasing direct ownership by 8% to 42,658 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 877d
  Patel Ronil A. covered exercise/tax liability with 1,282 shares, decreasing direct ownership by 1% to 90,714 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 886d
  Pepose Jay was granted 14,964 shares, increasing direct ownership by 16% to 107,315 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 886d
  Manuso James S J was granted 22,090 shares, increasing direct ownership by 32% to 90,894 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 886d
  Rodgers Richard J was granted 24,762 shares, increasing direct ownership by 14% to 198,008 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 886d
  Benton Susan was granted 19,418 shares, increasing direct ownership by 24% to 98,880 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 915d
  Patel Ronil A. was granted 49,692 shares, increasing direct ownership by 117% to 91,996 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 923d
  SEC Form 4 filed by Schachle Joseph K

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 923d
  SEC Form 3 filed by new insider Schachle Joseph K

  3 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 937d
  Pepose Jay was granted 35,000 shares, increasing direct ownership by 61% to 92,351 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 937d
  Rodgers Richard J was granted 35,000 shares, increasing direct ownership by 25% to 173,246 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 948d
  Magrath George was granted 400,000 shares (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 948d
  SEC Form 3 filed by new insider Magrath George

  3 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1095d
  SEC Form 4 filed by Manuso James S J

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1095d
  SEC Form 4 filed by Ainsworth Sean

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1095d
  SEC Form 4 filed by Pepose Jay

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1095d
  SEC Form 4 filed by Gallagher Cam

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1095d
  SEC Form 4 filed by Benton Susan

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1138d
  SEC Form 4 filed by Patel Ronil A.

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1138d
  SEC Form 3: New insider Patel Ronil A. claimed ownership of 22,304 shares

  3 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1143d
  SEC Form 4 filed by Benton Susan

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1143d
  SEC Form 4 filed by Manuso James S J

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1143d
  SEC Form 4 filed by Pepose Jay

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1143d
  SEC Form 4 filed by Rodgers Richard J

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1209d
  SEC Form 5: Sooch Mina gifted 130,000 shares and received a gift of 50,000 shares, decreasing direct ownership by 31% to 296,045 units

  5 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1209d
  SEC Form 5: Ainsworth Sean gifted 5,000 shares, decreasing direct ownership by 12% to 36,239 units

  5 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1242d
  SEC Form 4: Sooch Mina was granted 134,456 shares, increasing direct ownership by 45% to 430,501 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1242d
  SEC Form 4: Manuso James S J was granted 18,544 shares, increasing direct ownership by 51% to 55,009 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1242d
  SEC Form 4: Pepose Jay was granted 13,013 shares, increasing direct ownership by 40% to 45,907 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1242d
  SEC Form 4: Rodgers Richard J was granted 20,822 shares, increasing direct ownership by 31% to 88,246 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1242d
  SEC Form 4: Hoffmann Bernhard was granted 46,608 shares, increasing direct ownership by 47% to 146,728 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1242d
  SEC Form 4: Zaremba Rabourn Amy was granted 46,608 shares

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1242d
  SEC Form 4: Benton Susan was granted 16,267 shares, increasing direct ownership by 32% to 67,433 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1249d
  SEC Form 4: Gallagher Cam exercised 1,574 in-the-money shares at a strike of $0.00, increasing direct ownership by 7% to 24,928 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1326d
  SEC Form 4: Ainsworth Sean exercised 1,574 in-the-money shares at a strike of $0.00, increasing direct ownership by 4% to 41,239 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1334d
  SEC Form 4: Manuso James S J exercised 787 in-the-money shares at a strike of $0.00, increasing direct ownership by 2% to 36,465 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)